Home › Drug Approved In Pivotal Studies Using DSG's Fully Electronic Source Data
 

Keywords :   


Drug Approved In Pivotal Studies Using DSG's Fully Electronic Source Data

2015-03-04 04:49:19| drugdiscoveryonline Home Page

DSG, Inc and Sirion Therapeutics collaborated in launching the industry’s first two pivotal Phase 3 studies using entirely electronic source data collection for the safety and efficacy of Difluprednate in the management of inflammation following ocular surgery

Tags: data source fully studies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »